A detailed history of Bnp Paribas transactions in Bio N Tech Se stock. As of the latest transaction made, Bnp Paribas holds 90 shares of BNTX stock, worth $10,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 90 -0.0%
Holding current value
$10,255
Previous $7.23 Million 47.8%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$88.96 - $112.35 $8,006 - $10,111
90 New
90 $8.3 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.7B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Bnp Paribas Portfolio

Follow Bnp Paribas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas, based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas with notifications on news.